Cystic Fibrosis Research Today is a free monthly online journal that collates and summarizes the latest research about Cystic Fibrosis, including details on symptoms, genetics, treatment, information.

Volume 1 (2004), Issue 4 (December)

1. Elastic contributions dominate the viscoelastic properties of sputum from cystic fibrosis patients.
   Biophys Chem, 112(2): 193-200. [Abstract] [Full-text]
2. Prophylaxis and therapy of Pseudomonas aeruginosa infection in cystic fibrosis and immunocompromised patients.
   Vaccine, 22: S44-8. [Abstract] [Full-text]
3. Interleukin-8 in whole blood and clinical status in cystic fibrosis.
   Cytokine, 29(1): 18-23. [Abstract] [Full-text]
4. Genome diversity of Pseudomonas aeruginosa isolates from cystic fibrosis patients and the hospital environment.
   J Clin Microbiol, 42(12): 5783-92. [Abstract] [Full-text]
5. Burkholderia cepacia is associated with pulmonary hypertension and increased mortality among cystic fibrosis patients.
   J Clin Microbiol, 42(12): 5537-41. [Abstract] [Full-text]
6. Epidemiology of liver disease in cystic fibrosis: a longitudinal study.
   J Hepatol, 41(6): 920-5. [Abstract] [Full-text]
7. Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
   J Antimicrob Chemother, 54(6): 1057-61. [Abstract] [Full-text]
8. Myeloperoxidase and protein oxidation in the airways of young children with cystic fibrosis.
   Am J Respir Crit Care Med, 170(12): 1317-23. [Abstract] [Full-text]
9. Diabetes in an infant with cystic fibrosis.
   Pediatr Diabetes, 5(4): 199-201. [Abstract] [Full-text]
10. Abdominal manifestations of cystic fibrosis in adults: a review.
    Australas Radiol, 48(4): 450-8. [Abstract] [Full-text]
11. Management of a parturient with respiratory failure secondary to cystic fibrosis.
    Anaesthesia, 60(1): 77-80. [Abstract] [Full-text]
12. Malnutrition in adults with cystic fibrosis.
    Eur J Clin Nutr, 59(1): 152-4. [Abstract] [Full-text]
13. Fcgamma receptor IIA genotype and susceptibility to P. aeruginosa infection in patients with cystic fibrosis.
    Eur J Hum Genet, 13(1): 96-101. [Abstract] [Full-text]
14. Ultrase MT12 and Ultrase MT20 in the treatment of exocrine pancreatic insufficiency in cystic fibrosis: safety and efficacy.
    Aliment Pharmacol Ther, 20(11): 1365-71. [Abstract] [Full-text]
15. Swelling-activated Ca2+ entry via TRPV4 channel is defective in cystic fibrosis airway epithelia.
    J Biol Chem, 279(52): 54062-8. [Abstract] [Full-text]
16. Transbronchial biopsies provide longitudinal evidence for epithelial chimerism in children following sex mismatched lung transplantation.
    Thorax, 60(1): 60-2. [Abstract] [Full-text]
17. Sildenafil (Viagra) corrects DeltaF508-CFTR location in nasal epithelial cells from patients with cystic fibrosis.
    Thorax, 60(1): 55-9. [Abstract] [Full-text]
18. Peak oxygen uptake and mortality in children with cystic fibrosis.
    Thorax, 60(1): 50-4. [Abstract] [Full-text]
19. Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis.
    Thorax, 60(1): 22-6. [Abstract] [Full-text]
20. Use of phage display to identify potential Pseudomonas aeruginosa gene products relevant to early cystic fibrosis airway infections.
    Infect Immun, 73(1): 444-52. [Abstract] [Full-text]
21. Correction of the CF defect by curcumin: hypes and disappointments.
    Bioessays, 27(1): 9-13. [Abstract] [Full-text]
22. Cyclosporine-related neurotoxicity in a patient after bilateral lung transplantation for cystic fibrosis.
    Transplant Proc, 36(9): 2837-9. [Abstract] [Full-text]
23. Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces.
    J Hosp Infect, 59(2): 102-7. [Abstract] [Full-text]
24. Segregation analysis in cystic fibrosis at-risk family demonstrates that the M348K CFTR mutation is a rare innocuous polymorphism.
    Prenat Diagn, 24(12): 981-3. [Abstract] [Full-text]

© 2004-2010 Cystic Fibrosis Research Today. All Rights Reserved.